BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20077038)

  • 1. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.
    Kheirollahi M; Mehr-Azin M; Kamalian N; Mehdipour P
    Med Oncol; 2011 Mar; 28(1):7-14. PubMed ID: 20077038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.
    Malmer BS; Feychting M; Lönn S; Lindström S; Grönberg H; Ahlbom A; Schwartzbaum J; Auvinen A; Collatz-Christensen H; Johansen C; Kiuru A; Mudie N; Salminen T; Schoemaker MJ; Swerdlow AJ; Henriksson R
    J Neurooncol; 2007 May; 82(3):229-37. PubMed ID: 17151932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.
    Mehdipour P; Karami F; Javan F; Mehrazin M
    Mol Neurobiol; 2015 Aug; 52(1):293-302. PubMed ID: 25159481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
    Lin K; Adamson J; Johnson GG; Carter A; Oates M; Wade R; Richards S; Gonzalez D; Matutes E; Dearden C; Oscier DG; Catovsky D; Pettitt AR
    Clin Cancer Res; 2012 Aug; 18(15):4191-200. PubMed ID: 22675167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain.
    Chow LM; Endersby R; Zhu X; Rankin S; Qu C; Zhang J; Broniscer A; Ellison DW; Baker SJ
    Cancer Cell; 2011 Mar; 19(3):305-16. PubMed ID: 21397855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients.
    Lee KW; Tsai YS; Chiang FY; Huang JL; Ho KY; Yang YH; Kuo WR; Chen MK; Lin CS
    Ann Oncol; 2011 May; 22(5):1088-1093. PubMed ID: 21127011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation inhibition, DNA damage, and cell-cycle arrest of human astrocytoma cells after acrylamide exposure.
    Chen JH; Tsou TC; Chiu IM; Chou CC
    Chem Res Toxicol; 2010 Sep; 23(9):1449-58. PubMed ID: 20734998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.
    Shamma A; Suzuki M; Hayashi N; Kobayashi M; Sasaki N; Nishiuchi T; Doki Y; Okamoto T; Kohno S; Muranaka H; Kitajima S; Yamamoto K; Takahashi C
    Mol Cell Biol; 2013 Aug; 33(16):3113-24. PubMed ID: 23754744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences.
    Kodama M; Otsubo C; Hirota T; Yokota J; Enari M; Taya Y
    Mol Cell Biol; 2010 Apr; 30(7):1620-33. PubMed ID: 20123963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the genetic interactions between Cyclin A1, Atm and p53 during spermatogenesis.
    Baumer N; Sandstede ML; Diederichs S; Kohler G; Readhead C; Ji P; Zhang F; Bulk E; Gromoll J; Berdel WE; Serve H; Muller-Tidow C
    Asian J Androl; 2007 Nov; 9(6):739-50. PubMed ID: 17968459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway.
    Sugihara T; Murano H; Nakamura M; Ichinohe K; Tanaka K
    Mol Cancer Res; 2011 Apr; 9(4):476-84. PubMed ID: 21357441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
    Fordyce C; Fessenden T; Pickering C; Jung J; Singla V; Berman H; Tlsty T
    Cancer Prev Res (Phila); 2010 Feb; 3(2):190-201. PubMed ID: 20028875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.